Pieris Pharmaceuticals (PIRS) - Cash Funds Calculated per Share

Pieris Pharma - graphic logo of issuer PIRS

Pieris Pharmaceuticals (PIRS) possesses the potential for significant pricing power thanks to its Anticalin platform for targeted drug delivery. However, potential contract terminations with partners and a capital deficit create financial threats. The cash per share history clearly demonstrates liquidity, where the 16.15 level captures the current state. Diversified supply chains maintaining a strict cold chain ensure the continuity of research.

Pieris Pharmaceuticals Inc (PIRS) Cash per Single Share: for the period 07/04/2022 - 11/20/2026

Comprehensive metric breakdowns and analytics for Pieris Pharmaceuticals, Inc. (PIRS)

- market capitalization indicators:
- cash availability and cash flow indicators:
Summary company analysis:PIRS, Pieris Pharma
Manufactured products of pieris.com

This metric is calculated by dividing total cash and cash equivalents by the number of shares outstanding, determining the intrinsic liquidity value available to the holder of each security. For Pieris Pharmaceuticals (PIRS), in the absence of profitable products and amid cost-cutting measures, this calculation reflects the capital burn rate. Analyzing the current liquidity per share allows for an assessment of the company's survival runway before additional capitalization becomes necessary.

Analysis of competing companies

Cash on Hand per Share Haleon Corp HLN|Cash per Single Share KVUE (Kenvue Health)|Verona Pharma plc - Cash Funds per Single Share|Jyong Biotech - Cash per Single Share|LGND: Cash Funds per Single Share|AMRX: Cash per Single Share|Cash on Hand per Share Perrigo Company plc|ALVO: Cash per Share|Liquidia (LQDA) - Cash per Share|Cash Funds per Share Galapagos N.V.|Cash per Single Share ANI Pharmaceuticals, Inc. (ANIP)|Cash per Share MNKD|AMPH (Amphastar Corp) - Amount of Cash per Share|Cash Funds per Share pacira.com PCRX|SPRY - Cash per Single Share|Theravance Biopharma, Inc. - Cash per Share|Amount of Cash per Share AQST (Aquestive Therapeutics, Inc.)|SCPH: Cash per Share|Tectonic Therapeutic Inc. - Amount of Cash per Share|TNXP (Tonix Pharma) - Cash per Share|SXTC: Amount of Cash per Share|Cash per Share EPRX|BHST - Cash on Hand per Share|eXoZymes - Cash per Single Share|Cash per Share oramed.com ORMP|ENTX - Cash Funds per Share|Cash Funds Calculated per Share MindWalk Holdings HYFT|ABVC: Cash per Share|Cash per Single Share Cumberland Pharmaceuticals Inc.|Cash Funds per Share Quantum BioPharma Limited|FGEN: Amount of Cash per Share|Cash per Share TELO|Rani Therapeutics Holdings, Inc. - Cash Funds per Single Share|Cash Funds per Share Synergy CHC Corp. SNYR|Amount of Cash per Share RLYB|LEXX: Cash per Single Share|Amount of Cash per Share PULM (Pulmatrix Corporation)|Pheton Holdings Limited (PTHL) - Cash Funds per Share|Cash per Single Share Aptorum|Cash per Single Share LYRA|Impact BioMedical Inc - Cash Money per Share|Cash per Share TNFA|YCBD - Cash on Hand per Share|PainReform Ltd. - Cash per Single Share|CYTO (Auris Medical) - Cash Money per Share|LIPO - Cash Funds per Share|Amount of Cash per Share OPTN (OptiNose)|PROC: Cash per Share|Petros - Amount of Cash per Share|Cash per Single Share QLI|SLRN: Amount of Cash per Share|Cash per Single Share TFFP (TFF Pharmaceuticals, Inc.)